# Mallinckrodt Hospital Products

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mallinckrodt-hospital-products

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.cadencepharm.com
- Total disclosed funding: $79M
- Latest round: Series A (Mar 28, 2006)
- Investors on record: 9

## About

Mallinckrodt Hospital Products, Inc, formerly Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. In March 2015, Cadence Pharmaceuticals, Inc. changed its name to Mallinckrodt Hospital Products Inc.

## Funding rounds

- Series A, Mar 28, 2006, $54M — Domain Associates, Frazier Healthcare Partners, Technology Partners, Versant Ventures, Bellevue Group, CDIB BioScience Venture Management, BB Biotech, ProQuest Investments
- Series A, Oct 11, 2005, $25M — Domain Associates, Windamere Venture Partners, CDIB BioScience Venture Management, BB Biotech, ProQuest Investments

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A
- Windamere Venture Partners (https://capitalatlas.ai/funds/windamere-venture-partners) — Series A
- CDIB BioScience Venture Management (https://capitalatlas.ai/funds/cdib-bioscience-venture-management) — Series A
- BB Biotech (https://capitalatlas.ai/funds/bb-biotech) — Series A
- ProQuest Investments (https://capitalatlas.ai/funds/proquest-investments) — Series A
- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series A
- Technology Partners — Series A
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A
- Bellevue Group — Series A